- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04687462
Comparison of Polyethylene Insert Variances of Different Total Knee Arthroplasty System in the Same Patients
Comparison of 1-mm Thickness Variance Polyethylene Insert Total Knee Arthroplasty System and 2-mm Thickness Variance Polyethylene Insert Total Knee Arthroplasty System in the Same Patients
Total knee arthroplasty(TKA) is a successful orthopedic surgery with excellent clinical outcome and survival. However, there are concerns about patient satisfaction in previous reports, and dissatisfaction rate of 15-30% is reported in clinical outcomes(PROMs) of some studies. Therefore, for improving the patient's outcome and satisfaction after total knee arthroplasty, it is necessary to change the design of the conventional total knee arthroplsaty implant. The knee is a joint structure with several dynamic functions, and not only the skeletal structure but also the soft tissue balance plays an important role in the function of the knee joint. New implants are being developed to overcome the limitations of conventional TKA implant, including the Exult total knee system (Exult; Corentec). Exult implant has 1mm thickness variance of polyethylene insert, which is different from the conventional total knee systems. This new total knee system has been shown in experimental studies to produce nearly normal knee movement.
The clinical results of this more specific variance of polyethyelen insert thickness total knee implant system are insufficient, and there is also a lack of comparative studies with conventional total knee arthroplasty implant. The purpose of this study is to compare outcomes between 1-mm thickness variance polyethylene insert total knee arthroplasty system(Exult, total knee system, Corentec) and conventional 2-mm thickness variance polyethylene insert total knee arthroplasty system(Lospa total knee system, Corentec) in the same patients. This study is a randomized controlled study in patients undergoing both knee total knee arthroplasty in a day. Radiologic parameter, patients preference and clinical results was investigated in both knee of same patients who received TKA during minimum 2 year follow up.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yonggyu Sung, MD
- Phone Number: 821092160997
- Email: ygsung@catholic.ac.kr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Knee osteoarthritis patients for both total knee arthroplasty
- having medicare insurance
Exclusion Criteria:
- Rheumatoid arthritis
- Other inflammatory arthritis
- Crystal-induced arthritis
- Septic arthritis
- Neuropsychiatric patients
- Previous knee operation history
- Patients with preoperative severe limitation of motion (Flexion ontracture ≥ 20, range of motion ≤ 90)
- Patients with preoperative severe defomity of knee alignment (Varus or valgus angle ≥ 15)
- Severe obese patients (BMI ≥ 40)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
TKRA operation undergoing 1-mm thickness variance polyethylene insert total knee arthroplasty system (Exult, Corentec)
|
Device: 1-mm thickness variance polyethylene insert total knee arthroplasty system (Exult, Corentec)
TKRA operation undergoing 1-mm thickness variance polyethylene insert total knee arthroplasty system (Exult, Corentec)
|
|
Active Comparator: Control
TKRA operation undergoing 2-mm thickness variance polyethylene insert total knee arthroplasty system (Lospa, Corentec)
|
Device: 1-mm thickness variance polyethylene insert total knee arthroplasty system (Exult, Corentec)
TKRA operation undergoing 1-mm thickness variance polyethylene insert total knee arthroplasty system (Exult, Corentec)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Western Ontario and McMaster University Arthritis Index(WOMAC) pain scale
Time Frame: Preoperative & postoperative 3, 6, 12, 24 months
|
Changes of post-operative WOMAC score from pre-operative WOMAC scores at post-operative 3, 6, 12, 24 months WOMAC score ranges (0 ~ 96 in total score)
|
Preoperative & postoperative 3, 6, 12, 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Society Score
Time Frame: Preoperative & postoperative 3, 6, 12, 24 months
|
Changes of post-operative Knee Society Score from pre-operative Knee Society Score scores at post-operative 3, 6, 12, 24 months KSS score ranges (0 ~ 150 in total score)
|
Preoperative & postoperative 3, 6, 12, 24 months
|
|
Knee range of motion
Time Frame: Preoperative & postoperative 3, 6, 12, 24 months
|
Changes of post-operative knee ROM from pre-operative knee ROM at post-operative 3, 6, 12, 24 months (normal knee full range motion is 0 degree to 135 degrees in flexion)
|
Preoperative & postoperative 3, 6, 12, 24 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yong In, MD, PhD, the Catholic Univerisity of Korea Seoul St Mary's hospital
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- KC20DISI0965
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Knee Replacement Arthroplasty
-
Central DuPage HospitalTerminatedTotal Knee Replacement | Replacement, Total Knee | Arthroplasty, Knee ReplacementUnited States
-
Istanbul UniversityCompleted
-
Singapore General HospitalCompletedTotal Knee Arthroplasty | Total Knee ReplacementSingapore
-
Istanbul UniversityCompletedTotal Knee Arthroplasty | Total Knee ReplacementTurkey
-
Diakonhjemmet HospitalRecruitingKnee Arthroplasty, Total | Knee Replacement ArthroplastyNorway
-
University of AlbertaCompletedArthroplasty, Replacement, Knee | Knee Arthroplasty, TotalCanada
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedKnee Arthroplasty, Total | Knee Replacement, TotalUnited States
-
Solventum US LLCRecruitingArthroplasty Replacement, Knee | Arthroplasty Total Hip ReplacementUnited States
-
Mayo ClinicStryker OrthopaedicsCompletedArthroplasty, Replacement, Knee | Total Knee ReplacementUnited States
-
Rhode Island HospitalCompletedArthroplasty, Replacement, Knee | Total Knee ArthroplastyUnited States